Patent details

Basic Information

Publication number:

EP2379600

PCT Application Number:

EP2009067598

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097935431

PCT Publication Number:

WO2010072691

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR

French Title of Invention:

ANTICORPS DIRIGÉS CONTRE L'INHIBITEUR DE LA VOIE DU FACTEUR TISSULAIRE

German Title of Invention:

ANTIKÖRPER GEGEN GEWEBEFAKTOR-HEMMER

SPC Number:

Dates

Filing date:

18/12/2009

Grant date:

22/01/2014

EP Publication Date:

26/10/2011

PCT Publication Date:

01/07/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/10/2011

EP B1 Publication Date:

22/01/2014

EP B2 Publication Date:

14/10/2020

EP B3 Publication Date:

Lapsed date:

18/12/2014

Expiration date:

18/12/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/10/2020

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

1

Name:

LAURITZEN, Brian

Address:

Denmark (DK)

2

Name:

KROGH, Berit Olsen

Address:

Denmark (DK)

3

Name:

SØRENSEN, Brit Binow

Address:

Denmark (DK)

4

Name:

OLSEN, Ole Hvilsted

Address:

Denmark (DK)

5

Name:

HILDEN, Ida

Address:

Denmark (DK)

6

Name:

CLAUSEN, Jes Thorn

Address:

Denmark (DK)

7

Name:

BREINHOLT, Jens

Address:

Denmark (DK)

Priority

Priority Number:

08172520

Priority Date:

22/12/2008

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 39/395; A61P 7/04; C07K 16/38;

Publication

European Patent Bulletin

Issue number:

202042

Publication date:

14/10/2020

Description:

Patent maintained (B2 publication)

Filing date	Document type	Number of pages